HIGHLIGHTS
- who: from the Integrated Evidence Generation, Bayer AG, Berlin, Germany have published the paper: Long-TermAdherenceandPersistencetoLow-DoseAspirinforthe Prevention of Cardiovascular Disease: A Population-Based Cohort Study, in the Journal: International Journal of Clinical Practice of December/31,/2018
- what: The authors aimed to determine long-term (up to 10 years) adherence and persistence to lowdose aspirin for primary/secondary prevention of CVD. Using two such data sources from Germany and the United Kingdom (UK) and applying a standardised methodology, the authors aimed to describe long-term adherence and persistence (up to 10 years) to low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.